17 PhD fellowships in Parasitology in France

The international PhD program of the French national research network ‘ParaFrap’ is currently open for applications for 17 Ph.D. positions to be started in September 2021.

ParaFrap (http://www.labex-parafrap.fr/en/) is a Health Sciences collaborative research program focusing on Molecular and Cellular Parasitology in its wider sense. The network gathers 26 French leading groups in the field entirely devoted to modern parasitology using state-of-the-art research tools. The ParaFrap International Ph.D. program is an ambitious program offering competitive Ph.D. grants to high-quality students/early stage scientists. The call is international, opening applications to foreign students. Productive and motivated individuals with excellent organizational, interpersonal, and communication skills (both verbal and written) are strongly encouraged to apply. Qualified candidates should be interested in acquiring skills in the fields of molecular cell biology, drug discovery, immunology and pathophysiology for combatting worldwide parasitic diseases.

Successful applicants will be enrolled in one of the ParaFrap research groups, distributed among diverse French Universities. Information about the PhD research projects, selection process, as well as the application procedure, is available at http://www.labex-parafrap.fr/en/ and https://parafrap.application.systems . All applications MUST be made online on this second website.

The deadline for submitting an application is 10th April 2021.

Check Also

Barcelona (BSE) Scholarships 2024-25 to Study in Spain

Which program is right for me? We offer three Master’s Degrees at the Barcelona School …

One comment

  1. Votre page m’a plus et je suis très ravi de vos formations. Je veux solliciter auprès de votre bienveillance une possibilité de poursuivre avec les études posdoctorale car, je suis titulaire d’un doctorat unique de l’université Marien Ngouabi. Ma formation doctorale basée sur la recherche en biologie moléculaire m’a permis de de travailler sur l’efficacité thérapeutique des ACTs et les gènes de résistance du P.falciparum

Leave a Reply

Your email address will not be published. Required fields are marked *